Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
Go back to Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million| (NASDAQ: RCKT) | Delayed: 3.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.30 | 52 Week High | $ | |||
| Open | $3.30 | 52 Week Low | $ | |||
| Day High | $3.30 | P/E | N/A | |||
| Day Low | $3.30 | EPS | $ | |||
| Volume | 973 | |||||
